Relay Therapeutics Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | – | – | – | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | – | – | 1.1% | 3,216.6% | 5,349.2% | 6,629.9% | 9,008.8% | 12,331.0% | 16,578.4% | 19,447.7% | 25,267.6% | 36,649.1% | 74,118.5% | 323.4% | – | 823.5% | – | – | – | – | 9,080.1% | – | 8.6% | 16.8% | – | – | |
| – | – | – | – | – | – | – | 98.9% | -3,116.6% | -5,249.2% | -6,529.9% | -8,908.8% | -12,231.0% | -16,478.4% | -19,347.7% | -25,167.6% | -36,549.1% | -74,018.5% | -223.4% | – | -723.5% | – | – | – | 100.0% | -8,980.1% | – | 91.4% | 83.2% | 100.0% | -566.6% | |
| – | – | – | – | – | – | – | 38.0% | 3,216.6% | 19,922.6% | 6,752.9% | 9,154.7% | 12,331.0% | 16,578.4% | 19,447.7% | 26,591.7% | 36,649.1% | 74,118.5% | 323.4% | – | 823.5% | – | – | – | 961.2% | 9,438.3% | – | 791.6% | 2,352.1% | 21,852.3% | 2,615.7% | |
| – | – | – | – | – | – | – | 18.8% | 1,337.7% | 1,708.8% | 2,167.6% | 2,539.3% | 3,834.8% | 4,784.9% | 4,672.7% | 6,117.8% | 8,663.3% | 16,907.6% | 73.3% | – | 197.9% | – | – | – | 244.0% | 2,010.0% | – | 185.2% | 367.6% | 4,197.4% | 490.4% | |
| – | – | – | – | – | – | – | 56.6% | 1,337.7% | 17,686.8% | 2,627.8% | 3,035.3% | 2,738.2% | 4,839.7% | 5,620.9% | 3,627.3% | 8,219.5% | 15,099.2% | 68.6% | – | 179.5% | – | – | – | 1,205.2% | 2,371.0% | – | 957.6% | 2,702.9% | 26,049.7% | 2,432.8% | |
| – | – | – | – | – | – | – | 42.3% | -4,454.3% | -22,936.0% | -9,157.7% | -11,944.1% | -14,969.2% | -21,318.1% | -24,968.6% | -28,794.9% | -44,768.6% | -89,117.6% | -291.9% | – | -903.0% | – | – | – | -1,105.2% | -11,351.1% | – | -866.2% | -2,619.7% | -25,949.7% | -2,999.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | 166.1% | 275.3% | 498.0% | 1,349.4% | 3,069.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | 42.7% | -4,431.1% | -22,914.6% | -9,134.1% | -11,897.0% | -14,808.1% | -21,037.8% | -24,468.6% | -26,681.0% | -41,698.7% | -82,777.3% | -260.8% | – | -813.3% | – | – | – | -1,003.6% | -10,395.1% | – | -784.1% | -2,443.0% | -23,916.3% | -2,763.6% | |
| – | – | – | – | – | – | – | 0.3% | 23.2% | 21.4% | 23.6% | -147.4% | -2,520.5% | -220.5% | 898.5% | -9,560.5% | -3,069.9% | -8,160.5% | -5.4% | – | 13.5% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | 42.7% | -4,431.1% | -22,914.6% | -9,134.1% | -11,897.0% | -14,808.1% | -21,037.8% | -24,468.6% | -26,681.0% | -41,698.7% | -82,777.3% | -260.8% | – | -813.3% | – | – | – | -1,003.6% | -10,395.1% | – | -784.1% | -2,443.0% | -23,916.3% | -2,763.6% | |
| – | – | – | – | – | – | – | 43.8% | -4,357.8% | -6,844.2% | -8,705.4% | -11,455.6% | -15,833.2% | -21,001.4% | -23,720.1% | -32,501.6% | -44,682.7% | -89,805.0% | -291.3% | – | -907.4% | – | – | – | -987.8% | -10,247.1% | – | -826.4% | -2,426.2% | -23,669.4% | -2,771.8% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.